Given the complex heterogeneity of hepatic macrophages during NASH, our goal was to assess the importance of AMPK in all macrophages in the hepatic microenvironment during NASH progression. The gene discussed is PRKAA1; the disease is metabolic dysfunction-associated steatohepatitis.